Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)

Wegovy generated DKK 79.1 billion in net revenues for Novo Nordisk in 2025, a 35.9% increase year-on-year. Learn why NVO stock is a strong buy.

You will be redirected in 10 seconds.

liveinternet liveinternet